 "Ceiling prices of 691 formulations have been fixed under NELM 2022: Centre")
The government on Tuesday said that till July 17, ceiling prices have been fixed for 915 scheduled formulations.
Out of the total, ceiling prices of 691 formulations have been fixed under the National List of Essential Medicines (NLEM) 2022 and 224 formulations under NLEM 2015, Union Minister of State for Chemicals and Fertilisers Bhagwanth Khuba said in a written reply to Rajya Sabha.
Besides, the retail price of around 2,450 new drugs under Drugs (Prices Control) Order, 2013 has been fixed till July 7, 2023, he noted.
The minister also stated that a total of 5,772 complaints alleging overcharging were received by drug pricing regulatory body NPPA over the five-year period ranging between 2018-19 and 2022-23.
Replying to a query regarding the Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs), Khuba said 9,512 outlets are now functional across the country.
The product basket of PMBJP presently comprises about 1,800 medicines and 285 surgical devices, covering all major therapeutic groups, he noted.
The government has fixed a target for opening 10,000 PMBJKs by March 2024.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app